Stay updated with breaking news from Roberts rosenson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
E-Mail The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai. The fully human monoclonal antibody produced sustained reductions in triglyceride levels of up to 82 percent, depending on the patient s genotype, while also lowering the risk of recurrent acute pancreatitis. The results of the study will be presented as a late-breaking clinical trial at the American College of Cardiology (ACC) Annual Scientific Session, on May 16. Evinacumab has the potential to not only lower triglycerides, but the risk of acute pancreatitis, quality of life, and the risk of cardiovascular events in a highly vulnerable patient population, says Robert S. Rosenson, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and lead investigator of the study. The unmet clinical need couldn t be greater. Even after the cur ....
The Vatican s Pontifical Council for Culture and The Cura Foundation Unite to Prevent Global Leaders in Science, Faith, Medicine and Technology Gather for the Fifth International Vatican Conference News provided by Share this article Share this article VATICAN CITY and NEW YORK, April 15, 2021 /PRNewswire/ The Vatican s Pontifical Council for Culture and The Cura Foundation s Fifth International Vatican Conference will be held on May 6-8, 2021. The conference will unite the foremost leading physicians, scientists, leaders of faith, ethicists, patient advocates, policymakers, philanthropists and influencers to engage in powerful conversations on the latest breakthroughs in medicine, health care delivery and prevention, as well as the anthropological scientific and cultural impact of technological advances. ....